# Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration

> **NCT03680326** · — · COMPLETED · sponsor: **Hospital Hietzing** · enrollment: 43 (actual)

## Conditions studied

- Vitreomacular Interface

## Interventions

- **DEVICE:** OCT

## Key facts

- **NCT ID:** NCT03680326
- **Lead sponsor:** Hospital Hietzing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-02
- **Primary completion:** 2018-03-22
- **Final completion:** 2018-04-14
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03680326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03680326, "Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03680326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*